	Prognostic significance of TOP2A expression in bladder cancer: Systematic review and meta-analysis. Can Urol Assoc J Hendri AZ, Robert R, Febriyanto T, Liliana B, Pratama ADM, Oey O. PMID: 42531453 [PubMed - as supplied by publisher]
	Association between time from diagnosis to radical cystectomy and oncologic outcomes in muscle-invasive urothelial carcinoma of the bladder. Can Urol Assoc J Kim P, Kaul S, Fleishman A, Perez-Londono A, Kim S, Bellmunt J, Aghdam N, Olumi AF, Chang P, Wagner A, Gershman B. PMID: 42531446 [PubMed - as supplied by publisher]
	Investigation of a prostate cancer radiation response signature in the breast cancer SweBCG91RT randomized trial. Clin Cancer Res Zhao SG, Holmberg E, Lundstedt D, Killander F, Niméus E, Sharifi M, Sjöström M, Karlsson P. PMID: 42531378 [PubMed - as supplied by publisher]
	Concurrent Jackstone Calculus and Prostate Cancer: Should They Be Treated Concurrently or Sequentially? Am J Mens Health Tian S, Li H, Jiang Y, Wang C, Liu S, Wu F, Ning H. PMID: 42531155 [PubMed - indexed for MEDLINE]
	Patient-Provider Communication and Treatment Decision-Making among Latino Men with Prostate Cancer: A Qualitative Study. J Racial Ethn Health Disparities Rodriguez VE, Mendoza-Aguayo B, Rodriguez J, Ramirez CM, Soto D, Unger JB, Abreu AL, Ariani R, Baezconde-Garbanati L, Ballas L, Stern MC. PMID: 42530811 [PubMed - as supplied by publisher]
	Kinesins in Bladder Cancer: Integrating Molecular Mechanisms and Treatment Approaches. Cell Biol Int Sayed U, Basheer NM, H M, Nayak PP, Shankhyan A, Eshmetov R, Sadikova S, Ataullaev Z. PMID: 42529891 [PubMed - indexed for MEDLINE]
	Mapping therapy-responsive immune ecotypes in clear cell renal cell carcinoma through integrative omics. Front Immunol Zhang Z, He L, Chen B, Zhang H. PMID: 42529102 [PubMed - indexed for MEDLINE]
	PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencing. Oncol Rev Gierulska N, Jankowska N, Kwiatkowska A, Kuchno P, , Szklener K, Ko, Skórzewska M. PMID: 42529062 [PubMed]
	Awareness, risk perception, and attitudes toward prostate cancer detection and MRI among Armenian men. Front Public Health Shalunc NN, Gaboyan SS, Matinyan NG, Mnatsakanyan TS, Hovhannisyan MG, Ergas IJ. PMID: 42529047 [PubMed - indexed for MEDLINE]
	Case Report: Immune checkpoint inhibitor-induced IgG4-related disease mimicking renal metastatic progression: successful steroid-sparing management with rituximab. Front Immunol Bonatto ME, Dvo, Kollár M, Girsa D, Pr, Forejtová , Mann H, Vencovský J, Pavelka K, . PMID: 42528919 [PubMed - indexed for MEDLINE]
	Per- and Polyfluoroalkyl Substances Exposure in New Jersey Prostate Cancer Survivors: A Pilot Biomonitoring Study. medRxiv Joseph SA, Opara C, Shanahan MR, Varga J, Falcon J, Ibanga U, Venkatraman S, Perlstein M, Jang TL, Golombos D, Ghodoussipour S, Fan T, O'Leary S, Graber JM, Hart JE, Barrett ES, Bandera EV, Iyer HS. PMID: 42528551 [PubMed]
	Trends in the Adoption of MRI Associated Biopsy for Active Surveillance Within the First Year After Localized Prostate Cancer Diagnosis: A SEER-Medicare Cohort Study. Cancer Med Liu Y, Polychronopoulou E, Jackson J, Williams S, Kuo YF. PMID: 42528154 [PubMed - indexed for MEDLINE]
	Prognostic Factor Analysis and Nomogram Development in Castration-Resistant Prostate Cancer with Visceral Metastases for Future Radionuclide Therapy Selection. Cancer Biother Radiopharm Xu P, Lin X, Zhu Y, Chen J, Yang B. PMID: 42528049 [PubMed - as supplied by publisher]
	DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives. Drugs Pecoraro G, De Giorgi A, Montelatici G, Salfi G, Lin HM, Turco F, Taha T, Beltran H, de Bono J, Aggarwal RR, von Amsberg G, Joerger M, Imbimbo M, Colombo I, Gillessen S, Pedrani M. PMID: 42527846 [PubMed - as supplied by publisher]
	Pembrolizumab Plus Lenvatinib in Metastatic Renal Cell Carcinoma: Real-world Prognostic Factors. Anticancer Res Yamashita S, Yamasaki T, Ueda K, Tomida R, Toyoda S, Iwamoto H, Miyake M, Tomisaki I, Morizane S, Kohjimoto Y. PMID: 42527074 [PubMed - indexed for MEDLINE]
	Differences in Unmet Needs Between Older and Younger Patients With Advanced Renal Cell Carcinoma. Anticancer Res Negishi T, Furubayashi N, Kojima T, Nakano Y, Kataoka A, Nakamura M. PMID: 42527058 [PubMed - indexed for MEDLINE]
	Effectiveness and Safety of Enfortumab Vedotin Plus Pembrolizumab for Patients Aged 80 Years and Older With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study. Anticancer Res Kobari Y, Nakajima N, Saito A, Katsurayama N, Inakawa T, Kubota S, Nemoto Y, Nakamura K, Nishimura K, Ishihara H, Yagisawa T, Fukuda H, Yoshida K, Iizuka J, Shimmura H, Hashimoto Y, Kondo T, Kobayashi H, Takagi T. PMID: 42527056 [PubMed - indexed for MEDLINE]
	Can Engagement aid in design and accrual on Clinical Trials? Observations from COMPPARE - A Prospective Comparison of Outcomes with Proton and Photon Radiation in Prostate Cancer. Int J Radiat Oncol Biol Phys Mendenhall NP, Bryant CM, Katz AJ, Chen R, DeWees T, Hobkirk J, Bremer C, Grammel LW, Griggs C, Marckini R, Nelson R, Simons V, Odedina FT, Vapiwala N, Deville C Jr, Crisp AM, Morris CG. PMID: 42526648 [PubMed - as supplied by publisher]
	Precision targeting in prostate cancer: Mechanistic drivers and the evolving clinical pipeline. Drug Discov Today Nathe P, Singh Y, Ratre P, Kulkarni S. PMID: 42526626 [PubMed - as supplied by publisher]
	Comparison of 5-aminolevulinic acid-induced hypotension of extending the oral administration period during photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer. Photodiagnosis Photodyn Ther Fukuhara H, Shigehisa R, Yamamoto S, Fukata S, Saito K, Kamiya A, Shibanaka Y, Koga K, Inoue K. PMID: 42526612 [PubMed - as supplied by publisher]

Articles 1 - 20 / 180403

Page 1 of 9021



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy